These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15194161)

  • 21. Long-lived plasma cells and their contribution to autoimmunity.
    Hoyer BF; Manz RA; Radbruch A; Hiepe F
    Ann N Y Acad Sci; 2005 Jun; 1050():124-33. PubMed ID: 16014527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine phosphatase PTPN22 in human autoimmunity.
    Vang T; Miletic AV; Bottini N; Mustelin T
    Autoimmunity; 2007 Sep; 40(6):453-61. PubMed ID: 17729039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Theory of autoimmunity--my viewpoint].
    Hamashima Y
    Nihon Rinsho; 1968 Feb; 26(2):407-16. PubMed ID: 5302877
    [No Abstract]   [Full Text] [Related]  

  • 24. B cell depletion: on the rise.
    Hinze CH; Grom AA
    J Pediatr; 2007 Apr; 150(4):335-7. PubMed ID: 17382106
    [No Abstract]   [Full Text] [Related]  

  • 25. T-cells behaving badly: structural insights into alloreactivity and autoimmunity.
    Ely LK; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
    Curr Opin Immunol; 2008 Oct; 20(5):575-80. PubMed ID: 18678247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
    Youinou P; Renaudineau Y
    Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The T-box transcription factor T-bet in immunity and autoimmunity.
    Peng SL
    Cell Mol Immunol; 2006 Apr; 3(2):87-95. PubMed ID: 16696895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous immunogloblins: myth and reality.
    Tellier Z
    Isr Med Assoc J; 2005 Dec; 7(12):762-7. PubMed ID: 16382695
    [No Abstract]   [Full Text] [Related]  

  • 29. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleic acid recognizing Toll-like receptors and autoimmunity.
    von Landenberg P; Bauer S
    Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding autoimmune disease: new targets for drug discovery.
    Balagué C; Kunkel SL; Godessart N
    Drug Discov Today; 2009 Oct; 14(19-20):926-34. PubMed ID: 19596080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of B cells in SLE: rationale and therapeutic opportunities.
    Silverman GJ
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):51-6. PubMed ID: 17121490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S; Morva A; Youinou P; Jamin C
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic progress towards the molecular basis of autoimmunity.
    Pearce SH; Merriman TR
    Trends Mol Med; 2006 Feb; 12(2):90-8. PubMed ID: 16412690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin and autoimmunity.
    Zandman-Goddard G
    Isr Med Assoc J; 2010 Jan; 12(1):45-6. PubMed ID: 20450130
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug insight: rituximab in renal disease and transplantation.
    Salama AD; Pusey CD
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):221-30. PubMed ID: 16932428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-Glycosphingolipids as immune modulators.
    Adar T; Ilan Y
    J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autoimmunity and immune tolerance].
    Sorkin E
    Helv Med Acta; 1967; 33(4):53-60. PubMed ID: 5594800
    [No Abstract]   [Full Text] [Related]  

  • 40. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.
    Van Kaer L
    Nat Rev Immunol; 2005 Jan; 5(1):31-42. PubMed ID: 15630427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.